Financial Architects (New Jersey)’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-774	Closed	-$38K	–	276
2020 Q2	$38K	Buy	+774	New	+$37.2K	0.01%	461
2019 Q2	–	Sell	-670	Closed	-$18K	–	1181
2019 Q1	$18K	Sell	670 -200	-23%	-$4.67K	﹤0.01%	912
2018 Q4	$14K	Buy	870 +200	+30%	+$3.88K	﹤0.01%	902
2018 Q3	$14K	Sell	670 -450	-40%	-$7.08K	﹤0.01%	1006
2018 Q2	$17K	Buy	1,120 +200	+22%	+$3.57K	﹤0.01%	844
2018 Q1	$21K	Buy	920 +350	+61%	+$9.69K	﹤0.01%	869
2017 Q4	$17K	Buy	570 +450	+375%	+$14.4K	﹤0.01%	1005
2017 Q3	$5K	Sell	120 -1,100	-90%	-$35.8K	﹤0.01%	1261
2017 Q2	$34K	Buy	1,220 +800	+190%	+$23.8K	0.01%	799
2017 Q1	$14K	Sell	420 -630	-60%	-$22.2K	﹤0.01%	1039
2016 Q4	$30K	Sell	1,050 -350	-25%	-$9.26K	0.01%	715
2016 Q3	$45K	Buy	1,400 +800	+133%	+$27.1K	0.01%	597
2016 Q2	$19K	Buy	+600	New	+$20.1K	0.01%	793